Acrivon Therapeutics (ACRV) EV/EBITDA

EV/EBITDA

-1.76
+0.11+5.88%

Fri, 07 Feb 2025 21:59:29 GMT


Summary


Performance

ACRV EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherACRVvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

ACRV EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+5.9%-6.3%-5.0%
1 m1 month+5.4%-5.4%-4.3%
3 m3 months+34.1%-34.1%-29.1%
6 m6 months+26.1%-17.4%-15.7%
ytdytd-0.6%+0.2%+0.2%
1 y1 year-128.6%+188.0%+63.9%
5 y5 years---

ACRV EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-14.3%-2.07+15.0%
3 m3-month-1.53-15.0%-2.69+34.6%
6 m6-month-1.53-15.0%-3.57+50.7%
1 y1-year-0.68-158.8%-4.51+61.0%
3 y3-year-0.68-158.8%-14.99+88.3%
5 y5-year-0.68-158.8%-14.99+88.3%
alltimeall time-0.68-158.8%-14.99+88.3%

Acrivon Therapeutics EV/EBITDA History

DateValue
2025
-1.76(+0.6%)
2024
-1.75(+47.1%)
DateValue
2023
-1.19(-83.1%)
2022
-7.06

FAQ

  • What is Acrivon Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Acrivon Therapeutics?
  • What is ACRV EV/EBITDA year-to-date change?
  • What is Acrivon Therapeutics EV/EBITDA year-on-year change?

What is Acrivon Therapeutics EV/EBITDA?

The current EV/EBITDA of ACRV is -1.76

What is the all time high EV/EBITDA for Acrivon Therapeutics?

Acrivon Therapeutics all-time high EV/EBITDA is -0.68

What is ACRV EV/EBITDA year-to-date change?

Acrivon Therapeutics EV/EBITDA has changed by -0.01 (-0.57%) since the beginning of the year

What is Acrivon Therapeutics EV/EBITDA year-on-year change?

Over the past year, ACRV EV/EBITDA has changed by -0.99 (-128.57%)